Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells

被引:54
作者
Arnold, R [1 ]
König, B [1 ]
Werchau, H [1 ]
König, W [1 ]
机构
[1] Otto Von Guericke Univ, Inst Med Microbiol, D-39120 Magdeburg, Germany
关键词
ICAM-1; RANTES; IL-8; inflammation; NF-kappa B; RSV; A549; cell; soluble G protein;
D O I
10.1016/j.virol.2004.10.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Respiratory syncytial virus (RSV) is worldwide the single most important respiratory pathogen in infancy and early childhood. The G glycoprotein of RSV, named attachment protein, is produced by RSV-infected lung epithelial cells in both a membrane-anchored (mG protein) and a soluble form (sG protein) that is secreted by the epithelial cell. Currently, the biological role of the sG protein in primary RSV infection is still elusive. Therefore, we analyzed the inflammatory response of human lung epithelial cells (A549) infected either with wild-type RSV (RSV-WT) or a spontaneous mutant thereof deficient in the production of secreted G protein (RSV-DeltasG). Our data reveal that RSV-DeltasG, in comparison to RSV-WT, induced an increased cell surface expression of ICAM-1 on A549 cells and an enhanced release of the chemokines IL-8 and RANTES after 20 h postinfection. The increased protein expression pattern correlated with an enhanced mRNA level encoding for ICAM-1, IL-8, and RANTES, respectively. Furthermore, epithelial cells infected with RSV-DeltasG showed a more increased binding activity of the transcription factor NF-kappaB when compared to RSV-WT. In contrast, the mutant RSV-DeltasG replicated less efficiently in A549 cells than RSV-WT. Our data suggest that RSV, in the course of an ongoing infection, reduces by the production of sG protein the detrimental inflammatory response evolved by the infected resident lung epithelial cell and thereby supports its own replication. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:384 / 397
页数:14
相关论文
共 64 条
[51]   Respiratory syncytial virus bronchiolitis: Disease severity, interleukin-8, and virus genotype [J].
Smyth, RL ;
Mobbs, KJ ;
O'Hea, U ;
Ashby, D ;
Hart, CA .
PEDIATRIC PULMONOLOGY, 2002, 33 (05) :339-346
[52]   Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia [J].
Sparer, TE ;
Matthews, S ;
Hussell, T ;
Rae, AJ ;
Garcia-Barreno, B ;
Melero, JA ;
Openshaw, PJM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1921-1926
[53]  
Stark J, 1996, J IMMUNOL, V156, P4774
[54]   NF-κB:: a key role in inflammatory diseases [J].
Tak, PP ;
Firestein, GS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :7-11
[55]   Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus [J].
Tebbey, PW ;
Hagen, M ;
Hancock, GE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1967-1972
[56]   Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo [J].
Teng, MN ;
Whitehead, SS ;
Collins, PL .
VIROLOGY, 2001, 289 (02) :283-296
[57]   RANTES, macrophage-inhibitory protein 1α, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children [J].
Teran, LM ;
Seminario, MC ;
Shute, JK ;
Papi, A ;
Compton, SJ ;
Low, JL ;
Gleich, GJ ;
Johnston, SL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :677-681
[58]  
Thomas LH, 1998, J IMMUNOL, V161, P1007
[59]   CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein [J].
Tripp, RA ;
Jones, LP ;
Haynes, LM ;
Zheng, HQ ;
Murphy, PM ;
Anderson, LJ .
NATURE IMMUNOLOGY, 2001, 2 (08) :732-738
[60]   Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse [J].
Tripp, RA ;
Jones, L ;
Anderson, LJ .
JOURNAL OF VIROLOGY, 2000, 74 (13) :6227-6229